Default: Hepatology

ISSN: 0270-9139

Journal Home

Journal Guideline

Hepatology Q1 Unclaimed

John Wiley and Sons Ltd United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hepatology is a journal indexed in SJR in Medicine (miscellaneous) and Hepatology with an H index of 387. It has a price of 1900 €. It has an SJR impact factor of 4,152 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,152.

Hepatology focuses its scope in these topics and keywords: hepatitis, virus, liver, patients, chronic, hepatocellular, cells, factor, infection, immune, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


1900 €

Inmediate OA


Embargoed OA

0 €

Non OA




SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

hepatitis, virus, liver, patients, chronic, hepatocellular, cells, factor, infection, immune, injury, growth, risk, cell, mice, viral, nonalcoholic, hepatic, precore, mutant, lamivudine, human,

Best articles by citations

1204 Early HCV kinetics in immunosuppressed patients undergoing antiviral therapy: OLT vs. HIV-HCV coinfected vs. normal patients

View more

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection

View more

Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease

View more

Hepatitis C in asymptomatic blood donors

View more

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

View more

Advances in bioartificial liver devices

View more

Liver failure in children with hepatitis A

View more

Induction of interleukin-6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C

View more

Viral kinetics and hepatitis C

View more

Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with anmdr1agene disruption

View more

The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A

View more

Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C

View more

The role of TT virus infection in acute viral hepatitis

View more

Results of retransplantation for recurrent hepatitis C

View more

Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma

View more

Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C

View more

Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma

View more

Critical flicker frequency for quantification of low-grade hepatic encephalopathy

View more

Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats

View more

Determining the fate of hepatic cells by lineage tracing: Facts and pitfalls

View more

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C

View more

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

View more

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

View more

L-ornithine L-aspartate in bouts of overt hepatic encephalopathy

View more